Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecfidera in secondary progressive multiple sclerosis
NCT02430532Phase 3Terminated
- Sponsor
- Biogen
- Start
- May 2015
- Primary completion
- Jan 2016
- Countries
- 6
01
Overview
A Phase 3 trial of dimethyl fumarate in Secondary Progressive Multiple Sclerosis (SPMS), sponsored by Biogen. Started May 2015; status: terminated.
02
Drugs
dimethyl fumarate
03
Conditions
Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT02430532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02430532.